Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 6/20 | 0.39 |
| ▸ | PPARD | Q03181 | 6/20 | 0.39 |
| ▸ | PPARA | Q07869 | 6/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.39 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | FABP4 | P15090 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9082669 | 0.95 | GAA (0.46) | TDP1KMT2AL3MBTL1ALDH1A1MAPT | |
| SCHEMBL380843 | 0.95 | TDP1 (0.44) | TDP1KMT2AL3MBTL1ALDH1A1MAPT | |
| SCHEMBL9083965 | 0.95 | TDP1 (0.44) | TDP1KMT2AL3MBTL1ALDH1A1MAPT | |
| SCHEMBL381167 | 0.95 | GAA (0.46) | TDP1KMT2AL3MBTL1ALDH1A1MAPT | |
| SCHEMBL9084194 | 0.95 | TDP1 (0.44) | TDP1KMT2AL3MBTL1ALDH1A1MAPT | |
| SCHEMBL9084278 | 0.93 | FDPS (0.47) | TDP1KMT2AALDH1A1GAAPPARG | |
| SCHEMBL380077 | 0.93 | FDPS (0.47) | TDP1KMT2AALDH1A1GAAPPARG | |
| SCHEMBL381619 | 0.92 | GAA (0.47) | ALDH1A1GAAAKR1B1PPARGPPARD | |
| SCHEMBL630616 | 0.91 | KMT2A (0.42) | TDP1KMT2AL3MBTL1ALDH1A1MAPT | |
| SCHEMBL380072 | 0.90 | FDPS (0.48) | TDP1KMT2AALDH1A1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3793973-B1 | PROCESS FOR PRODUCING AN INTRAMOLECULAR DIESTER OF A HYDROXYCARBOXYLIC ACID AND PROCESS FOR PRODUCING A POLYHYDROXYCARBOXYLIC ACID. | FRAUNHOFER GES FORSCHUNG (DE) | 2022-12-28 | — | — | EP | claimed |
| EP-3793973-A1 | PROCESS FOR PRODUCING AN INTRAMOLECULAR DIESTER OF A HYDROXYCARBOXYLIC ACID AND PROCESS FOR PRODUCING A POLYHYDROXYCARBOXYLIC ACID. | FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. (DE) | 2021-03-24 | — | — | EP | claimed |
| EP-2788326-B1 | N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE | GALDERMA RES & DEV (FR) | 2019-04-24 | — | — | EP | claimed |
| CN-106067330-A | Chip inductor this utility model claims a silver paste | 西安立伟电子科技有限责任公司 | 2016-11-02 | — | — | CN | claimed |
| US-9452120-B2 | N-(pyrid-4-yl)amides and N-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2016-09-27 | — | — | US | claimed |
| EP-2788326-A1 | N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE | Galderma Research & Development (FR) | 2014-10-15 | — | — | EP | claimed |
| CN-104039767-A | N- (pyridin-4-yl) amides and N- (pyrimidin-4-yl) amides and their pharmaceutical and cosmetic use | GALDERMA RES & DEV | 2014-09-10 | — | — | CN | claimed |
| US-20140234245-A1 | N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2014-08-21 | — | — | US | claimed |
| WO-2013064681-A1 | N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2013-05-10 | — | — | WO | claimed |
| EP-1569979-B1 | USE OF A MATERIAL FOR NOISE PROTECTION DEVICES, SWIMMING PROTECTION DEVICES, OTOPLASTICS AND FOR SECURING VENTINGS AND METHOD FOR THE PRODUCTION OF SAID PARTS | DREVE OTOPLASTIK GMBH (DE) | 2012-02-22 | — | — | EP | claimed |
| US-20050069504-A1 | Coating for nail care having antimicrobial properties | BEAURLINE DANIEL J (US) | 2005-03-31 | — | — | US | claimed |
| WO-2003045339-A2 | COATING FOR NAIL CARE HAVING ANTIMICROBIAL PROPERTIES | ALMELL, LTD. (US) | 2003-06-05 | — | — | WO | claimed |
| US-12595626-B2 | Aqueous biodegradable-resin dispersion, production method therefor, and food-packaging paper obtained using aqueous biodegradable-resin dispersion | MIYOSHI OIL & FAT CO., LTD. (JP) | 2026-04-07 | — | — | US | disclosed |
| EP-4520797-A1 | DISPERSION | Chukyo Yushi Co., Ltd. (JP) | 2025-03-12 | — | — | EP | disclosed |
| US-20250051621-A1 | BIODEGRADABLE RESIN AQUEOUS DISPERSION HAVING EXCELLENT LONG-TERM STORAGE STABILITY AND METHOD FOR USING SAME | MIYOSHI OIL & FAT CO., LTD. (JP) | 2025-02-13 | — | — | US | disclosed |
| WO-2025013146-A1 | DISPERSION | 中京油脂株式会社 | 2025-01-16 | — | — | WO | disclosed |
| US-4421881-A | NAIL POLISH | DEL LABORATORIES, INC. | 1983-12-20 | — | — | US | disclosed |
| EP-0061348-A1 | Nitrocellulose lacquer composition containing gelatin and acrylic copolymers | A.H. ROBINS COMPANY, INCORPORATED (US) | 1982-09-29 | — | — | EP | disclosed |
| US-4208423-A | Anticholinergic bronchodilators | SYNTEX INC. (US) | 1980-06-17 | — | — | US | disclosed |
| US-4126675-A | METHYL METHACRYLATE-HEXYL METHACRYLATE COPOLYMER, PLASTICIZER, SOLVENT, FILMING AGENT | L'OREAL (FR) | 1978-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140234245-A1 | N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE | NR5A1, AR, CYP19A1 | TDP1 3993/4885KMT2A 1562/4885L3MBTL1 4847/4885 |
| US-12595626-B2 | Aqueous biodegradable-resin dispersion, production method therefor, and food-packaging paper obtained using aqueous biodegradable-resin dispersion | PPA1, PHYKPL, LCP1 | TDP1 451/4885KMT2A 3746/4885L3MBTL1 1342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.